Results 351 to 360 of about 1,994,828 (407)
Some of the next articles are maybe not open access.
Histopathology, 2019
To characterise the mutational profiles of poorly differentiated thyroid carcinoma (PDTC) and anaplastic thyroid carcinoma (ATC) and to identify markers with potential diagnostic, prognostic and therapeutic significance.
Huanli Duan +12 more
semanticscholar +1 more source
To characterise the mutational profiles of poorly differentiated thyroid carcinoma (PDTC) and anaplastic thyroid carcinoma (ATC) and to identify markers with potential diagnostic, prognostic and therapeutic significance.
Huanli Duan +12 more
semanticscholar +1 more source
Endocrine Practice, 2013
This review outlines advances in the diagnosis, genetic testing, and progress in medullary thyroid cancer (MTC) treatment in light of the most recent evidence.English-language articles pertaining to MTC published up to 2012 were reviewed. The pertinent articles and their references were obtained and those considered relevant were reviewed for inclusion.
Marcio L, Griebeler +2 more
openaire +2 more sources
This review outlines advances in the diagnosis, genetic testing, and progress in medullary thyroid cancer (MTC) treatment in light of the most recent evidence.English-language articles pertaining to MTC published up to 2012 were reviewed. The pertinent articles and their references were obtained and those considered relevant were reviewed for inclusion.
Marcio L, Griebeler +2 more
openaire +2 more sources
Current Opinion in Endocrinology, Diabetes & Obesity, 2021
Purpose of review To summarize recent developments in the diagnosis and management of patients with medullary thyroid cancer (MTC), with a focus on pathogenesis, systemic therapy, and future directions. Recent findings The addition of mutational analysis to cytological assessment of
Tania, Jaber, Ramona, Dadu, Mimi I, Hu
openaire +2 more sources
Purpose of review To summarize recent developments in the diagnosis and management of patients with medullary thyroid cancer (MTC), with a focus on pathogenesis, systemic therapy, and future directions. Recent findings The addition of mutational analysis to cytological assessment of
Tania, Jaber, Ramona, Dadu, Mimi I, Hu
openaire +2 more sources
Seminars in Diagnostic Pathology, 2020
Anaplastic thyroid carcinoma (ATC) is a rare but significant malignancy due to its high mortality rate. Rendering an accurate diagnosis is crucial given the prognostic implications and treatment ramifications. Based on the prognostic significance of the extent of invasion of the primary tumor, T staging for ATC changed in the most recent edition of the
Jing, Yang, Justine A, Barletta
openaire +2 more sources
Anaplastic thyroid carcinoma (ATC) is a rare but significant malignancy due to its high mortality rate. Rendering an accurate diagnosis is crucial given the prognostic implications and treatment ramifications. Based on the prognostic significance of the extent of invasion of the primary tumor, T staging for ATC changed in the most recent edition of the
Jing, Yang, Justine A, Barletta
openaire +2 more sources
1997
During the past years advances have been made in the understanding of the molecular mechanisms involved in the initiation and progression of thyroid carcinoma. Mutations in tumor suppressor genes such as p53 and oncogenes such as N-ras may be important for progression of well-differentiated thyroid carcinomas.
A M, Gillenwater, R S, Weber
openaire +2 more sources
During the past years advances have been made in the understanding of the molecular mechanisms involved in the initiation and progression of thyroid carcinoma. Mutations in tumor suppressor genes such as p53 and oncogenes such as N-ras may be important for progression of well-differentiated thyroid carcinomas.
A M, Gillenwater, R S, Weber
openaire +2 more sources
The Irish Journal of Medical Science, 1959
Two cases of slowly growing carcinomata of the thyroid gland with specific features are reported. Attention is drawn to the anachronisms associated with the term “lateral aberrant thyroid” and “benign metastasizing tumours of the thyroid” and to the confusion of thought surrounding the origin, course and codification of those tumours.
F J, MORRIN, M J, O'HALLORAN
openaire +2 more sources
Two cases of slowly growing carcinomata of the thyroid gland with specific features are reported. Attention is drawn to the anachronisms associated with the term “lateral aberrant thyroid” and “benign metastasizing tumours of the thyroid” and to the confusion of thought surrounding the origin, course and codification of those tumours.
F J, MORRIN, M J, O'HALLORAN
openaire +2 more sources
The Journal of Clinical Endocrinology & Metabolism, 1958
Data regarding 17 cases of thyroid carcinoma persistent for ten to twenty-six years are reported. The ages of the patients at the time of the initial treatment varied from 8 to 56 years, and the tumors included all types of thyroid cancer. Only 1 tumor became histologically more anaplastic with persistence; all others were histologically similar at ...
W A, MEISSNER, M A, LEGG
openaire +2 more sources
Data regarding 17 cases of thyroid carcinoma persistent for ten to twenty-six years are reported. The ages of the patients at the time of the initial treatment varied from 8 to 56 years, and the tumors included all types of thyroid cancer. Only 1 tumor became histologically more anaplastic with persistence; all others were histologically similar at ...
W A, MEISSNER, M A, LEGG
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2007
Medullary thyroid carcinoma is a neuroendocrine tumor derived from the C cells of the thyroid gland and accounts for approximately 5% of all thyroid carcinomas. Approximately 30% of the cases are associated with an autosomal dominant syndrome called multiple endocrine neoplasia type 2, and the identification of these individuals is important because ...
Ana O, Hoff, Paulo M, Hoff
openaire +2 more sources
Medullary thyroid carcinoma is a neuroendocrine tumor derived from the C cells of the thyroid gland and accounts for approximately 5% of all thyroid carcinomas. Approximately 30% of the cases are associated with an autosomal dominant syndrome called multiple endocrine neoplasia type 2, and the identification of these individuals is important because ...
Ana O, Hoff, Paulo M, Hoff
openaire +2 more sources
Current Treatment Options in Oncology, 2003
Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy that occurs in hereditary (25%) and sporadic (75%) clinical settings. MTC is present in all patients with the multiple endocrine neoplasia type 2 syndromes. MTCs produce calcitonin, the measurement of which can indicate the presence of tumors in people who are at risk and the ...
openaire +2 more sources
Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy that occurs in hereditary (25%) and sporadic (75%) clinical settings. MTC is present in all patients with the multiple endocrine neoplasia type 2 syndromes. MTCs produce calcitonin, the measurement of which can indicate the presence of tumors in people who are at risk and the ...
openaire +2 more sources
2011
Abstract Medullary thyroid carcinoma (MTC) is a rare calcitonin-secreting tumour of the parafollicular or C cells of the thyroid. As the C cells originate from the embryonic neural crest, MTC often have the clinical and histological features of neuroendocrine tumours.
Friedhelm Raue, Karin Frank-Raue
openaire +1 more source
Abstract Medullary thyroid carcinoma (MTC) is a rare calcitonin-secreting tumour of the parafollicular or C cells of the thyroid. As the C cells originate from the embryonic neural crest, MTC often have the clinical and histological features of neuroendocrine tumours.
Friedhelm Raue, Karin Frank-Raue
openaire +1 more source